Q32 Bio

View the org chart displaying its 13 main executives

Most searched biographies at Q32 Bio

• Jodie Morrison, Acting Chief Executive Officer
• Davidi Grayzel, Director
• Diyong Xu, Director

Popular executive movements at Q32 Bio

• Lee Kalowski has joined the company as President and Chief Financial Officer  (posted on April 5 2024).
• Saul Fink has joined the company as Chief Technology Officer  (posted on October 25 2023).

Create your alert
to follow the executive moves at Q32 Bio.

Q32 Bio has 2,293 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Merck has announced the acquisition of EyeBio  (posted on May 31 2024).
• Actuate Therapeutics has just announced a $50 Million fundraising (posted on May 29 2024).
• Grey Wolf Therapeutics has just announced a $50 Million fundraising (posted on May 25 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Q32 Bio

• Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update - Q32 Bio Inc.
• Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer - Q32 Bio Inc.
• News - Q32

Social media about Q32 Bio

• Q32 Bio on Wikipedia, Google News & Yahoo Finance
• Q32 Bio on LinkedIn, Twitter & YouTube

Contact by email its executives including Jodie Morrison

Call Q32 Bio at +1 917...

View the org chart

Register to receive your alert

Report an error